• Return to Headlines

Sarepta Therapeu: 52-Week High Recently Eclipsed (SRPT)

By Nick Russo

Shares of Sarepta Therapeu (NASDAQ:SRPT) traded at a new 52-week high today of $100.68. So far today approximately 293,000 shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

Over the past year, Sarepta Therapeu has traded in a range of $30.09 to $100.68 and is now at $99.70, 231% above that low. The 200-day and 50-day moving averages have moved 1.46% higher and 1.82% higher over the past week, respectively.

There is potential upside of 0.4% for shares of Sarepta Therapeu based on a current price of $99.70 and an average consensus analyst price target of $100.08. The stock should discover initial support at its 50-day moving average (MA) of $86.09 and subsequent support at its 200-day MA of $64.38.

SmarTrend recommended that subscribers consider buying shares of Sarepta Therapeu on April 11th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $79.45. Since that recommendation, shares of Sarepta Therapeu have risen 24.3%. We continue to monitor SRPT for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows sarepta therapeu

Ticker(s): SRPT